TBCRC048: Metastatic Breast Cancer, BRCA Gene Mutation
What is the Purpose of this Study?
Who Can Participate in this Study?
Adults who have:
- Stage IV metastatic breast cancer
- BRCA gene mutation (germline mutation or a somatic mutation)
--- If you have the mutation, you may not have progressed (gotten worse) on more than 2 chemotherapy regimens in the metastatic setting
What is Involved?
If you choose to join this study, you will:
- Get the study drug olaparib during each 21 day treatment cycle
- Have tests, exams and procedures that are part of your standard of care and for study purposes.